Lincode Non-targeting Pool


Negative control pool of four siRNAs with three or more mismatches to any human, mouse or rat lncRNA or protein-coding gene. Dual-strand modifications reduce potential off-targets. Ideal for determination of baseline cellular responses in RNAi experiments.
Lincode Non-targeting Control Pool is the ideal negative control for RNAi experiments for knockdown of human long, noncoding RNAs (lncRNAs). The four component Lincode Non-targeting siRNAs are designed to leverage seed-region optimization and proprietary dual-strand modification patterns to have fewer off-targets than traditionally designed negative control siRNAs. Changes in cells treated with these controls reflect a baseline cellular response that can be compared to the levels in cells treated with target-specific siRNA.

Highlights

  • Ideal negative control for RNAi experiments in human, mouse, and rat cells
  • Chemically matched for use with Lincode siRNA reagents
  • Screened by genome-wide microarray analysis for minimal off-targets
Please note: this control is identical to the ON-TARGETplus Non-targeting Control Pool (Cat# D-001810-10). It is also being sold under the Lincode name for ease of ordering by customers new to RNAi. Either catalog item is suitable for Lincode and ON-TARGETplus siRNA experiments.
  
HazardousNo
Shipping ConditionAmbient
Stability at Recommended Storage ConditionsAt least 12 months
Storage Condition-20 C
Cartoon showing Lincode siRNA modifications reducing seed-mediated off-targeting and inactivation of the passenger strand.

Sense strand activity is prevented by siRNA modifications

Cartoon showing Lincode siRNA modifications reducing seed-mediated off-targeting and inactivation of the passenger strand.

Lincode siRNAs are modified with a proprietary dual-strand modification that improves siRNA functionality. Additionally, off-targets are reduced due to:

  • Inactivation of passenger strand activity; driving preferential loading of the guide strand into RISC
  • Novel seed region modifications for disruption of microRNA-like off-targets